OBD — Oxford Biodynamics Balance Sheet
0.000.00%
- £9.30m
- £10.18m
- £0.64m
Annual balance sheet for Oxford Biodynamics, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11.5 | 4.34 | 0.999 | 5.25 | 2.83 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.833 | 1.71 | 1.08 | 1.05 | 1.26 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 12.9 | 6.68 | 2.77 | 7.17 | 5.05 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.18 | 7.55 | 6.98 | 7 | 5.71 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 14.9 | 15.4 | 11.3 | 16.1 | 12.1 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.29 | 2.29 | 2.91 | 4 | 2.56 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.79 | 8.7 | 8.76 | 10.1 | 7.75 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 13.1 | 6.68 | 2.59 | 6.05 | 4.36 |
| Total Liabilities & Shareholders' Equity | 14.9 | 15.4 | 11.3 | 16.1 | 12.1 |
| Total Common Shares Outstanding |